Skip to content
Screener

Precigen PGEN Q3 2025 earnings

Reported November 13, 2025 · After market close

Revenue$2.9MMiss by $5.4M
EPS-$0.11Miss by $0.03
Revenue estimate$8.3M
EPS estimate-$0.08

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$69.2M
EPS estimate$0.09

Financials

Q3 2025

Income statement

See full
Net income-$146.3M-510%
EPS (diluted)-$1.06-1,078%

Balance sheet

See full
Cash & equivalents$14.3M-42.1%
Total debt$98.2M+1,608%
Total equity$41.9M-24.4%
Total assets$171.3M+105%

Cash flow

See full
Operating cash flow-$29.1M-27.9%
CapEx$389.0K-55.9%
Free cash flow-$29.5M-24.7%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.16B+386%
Enterprise value$1.24B+466%

Returns & leverage

See full
Return on equity-507.7%-808pp
Debt / equity2.3×+2.2×
Current ratio4×+2.4×

FAQ

When did Precigen report Q3 2025 earnings?
Precigen (PGEN) reported Q3 2025 earnings on November 13, 2025 after market close.
What were Precigen's Q3 2025 revenue and EPS?
Precigen reported revenue of $2.9M and eps of $-0.11 for Q3 2025.
Did Precigen beat estimates in Q3 2025?
Revenue missed the consensus estimate of $8.3M by $5.4M. EPS missed the consensus estimate of $-0.08 by $0.03.
How did Precigen's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 206.6% from $953.0K a year earlier and eps declined 22.2% from $-0.09.
Where can I find Precigen's Q3 2025 SEC filings?
You can read the 8-K earnings release (0000950103-25-014683) and the 10-Q periodic report (0001356090-25-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.